A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Y. Yao, Y. Zhang, Z. Li, Z. Chen, X. Wang, Z. Li, L. Yu, X. Cheng, W. Li, W.-J. Jiang, H.-J. Wu, Z. Feng, J. Sun, T. Fei
This study uses deep learning to screen FDA-approved drugs and TCM compounds for anti-SARS-CoV-2 activity by targeting cell entry, identifying several effective candidates.
bioRxiv · Jun 3, 2023Microbiology